2023 Exhibits & Sponsors

Elevate your brand and engage attendees by becoming an exhibitor and/or sponsor at the IARS or SOCCA 2023 Annual Meetings.

All exhibitors/sponsors receive:

SOCCA Annual Meeting

  • One Complimentary registration to SOCCA Annual Meeting
  • Listing on Annual Meeting Website, 75-word company description plus logo and link
  • Recognition in one SOCCA Annual Meeting e-blast

IARS Annual Meeting

  • One Complimentary registration to IARS Annual Meeting
  • Listing on Annual Meeting Website, 75-word company description plus logo and link
  • Recognition in one IARS Annual Meeting e-blast

Questions? Email [email protected]

Thank you to our 2023 IARS and SOCCA Exhibitors!

IARS Exhibitors

The American Society of Anesthesiologists® (ASA®) is your professional champion, supporting your success at every stage of your career, across every subspecialty, and in every practice setting. ASA is a global community that advances the standards of anesthesiology practice and quality, improves patient care and safety, and secures the future of the specialty. Stop by the booth to preview ANESTHESIOLOGY® and ASA Monitor®, the official publications of the ASA.

La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. GIAPREZA™ (angiotensin II) is approved by the U.S. Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) is approved by the U.S. FDA for the treatment of complicated intra-abdominal infections.

SmartTots is a Public-Private Partnership (PPP) between the US Food and Drug Administration (FDA) and the International Anesthesia Research Society (IARS). The mission of this partnership is to coordinate and fund a research program with the goal of ensuring safe surgery for the millions of infants and young children who undergo anesthesia and/or sedation each year.

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. Our solutions help to build clinical competency and improve practice so that healthcare organizations can succeed in value-based care delivery models. Wolters Kluwer is proud to be the official publisher of the IARS.

SOCCA Exhibitors

La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. GIAPREZA™ (angiotensin II) is approved by the U.S. Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) is approved by the U.S. FDA for the treatment of complicated intra-abdominal infections.